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Abstract
Background: Insulin resistance (IR) has been associated with cardiovascular diseases (CVD). Heart rate variability
(HRV), an index of cardiac autonomic modulation (CAM), is also associated with CVD mortality and CVD morbidity.
Currently, there are limited data about the impairment of IR on the circadian pattern of CAM. Therefore, we
conducted this investigation to exam the association between IR and the circadian oscillations of CAM in a
community-dwelling middle-aged sample.
Method: Homeostasis models of IR (HOMA-IR), insulin, and glucose were used to assess IR. CAM was measured by
HRV analysis from a 24-hour electrocardiogram. Two stage modeling was used in the analysis. In stage one, for
each individual we fit a cosine periodic model based on the 48 segments of HRV data. We obtained three
individual-level cosine parameters that quantity the circadian pattern: mean (M), measures the overall average of a
HRV index; amplitude (Â), measures the amplitude of the oscillation of a HRV index; and acrophase time (θ),
measures the timing of the highest oscillation. At the second stage, we used a random-effects-meta-analysis to
summarize the effects of IR variables on the three circadian parameters of HRV indices obtained in stage one of
the analysis.
Results: In persons without type diabetes, the multivariate adjusted b (SE) of log HOMA-IR and M variable for HRV
were -0.251 (0.093), -0.245 (0.078), -0.19 (0.06), -4.89 (1.76), -3.35 (1.31), and 2.14 (0.995), for log HF, log LF, log VLF,
SDNN, RMSSD and HR, respectively (all P < 0.05). None of the IR variables were significantly associated with Â or θ
of the HRV indices. However, in eight type 2 diabetics, the magnitude of effect due to higher HOMA-IR on M, Â,
and θ are much larger.
Conclusion: Elevated IR, among non-diabetics significantly impairs the overall mean levels of CAM. However, the Â
or θ of CAM were not significantly affected by IR, suggesting that the circadian mechanisms of CAM are not
impaired. However, among persons with type 2 diabetes, a group clinically has more severe form of IR, the adverse
effects of increased IR on all three HRV circadian parameters are much larger.
Background
Insulin resistance (IR) is a precursor and a characteristic
feature of type 2 diabetes [1]. IR is also associated with
higher risk of cardiovascular diseases (CVD) [2,3].
Homeostasis model assessment of IR (HOMA-IR) has
been applied to quantify IR in people with or without
glucose intolerance, and it has been a reliable tool in the
assessment of IR, especially before the clinical diagnosis
of type 2 diabetes [4,5].
Heart rate variability (HRV), an index of cardiac auto-
nomic modulation (CAM) [6] is associated with CVD
mortality and CVD morbidity in various populations
[7-13]. Several epidemiological studies have shown that
individuals with IR or increased fasting glucose [14]
have increased heart rate [14-16] and reduced HRV
[14,16,17]. Galinier et al. demonstrated that patients
with hyperinsulinemia or IR had a significant decrease
in HRV [18]. In the population-based Atherosclerosis
Risk in communities study, a consistent association
between IR, metabolic syndrome and impaired CAM
has been reported [12,19-23]. However, all of these stu-
dies were based on the overall mean levels of HRV.
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CAM, [24-26] which can be quantified with a cosine
periodic regression model consisting of three cosine
function parameters: mean (M), amplitude (Â), and
acrophase (θ). The cosine function parameter M mea-
sures the overall average of a HRV index, the Â mea-
sures the amplitude of the oscillation of a HRV index,
and the θ measures the clock time when the highest
oscillation (amplitude) is reached. Lack of circadian var-
iation of HRV is associated with increased vulnerability
to cardiovascular events [27]. However, no study has
examined the quantitative effect of insulin resistance on
the three major circadian parameters that quantity the
circadian pattern of CAM. Therefore, the objective of
this study is to examine the effects of IR on the circa-
dian pattern of CAM in a community-dwelling sample
of non-diabetics.
Methods
Study population
For this report, we used the data collected for the Air
Pollution and Cardiac Risk and its Time Course
(APACR) study, which we designed to investigate the
mechanisms and the time course of the adverse effects
of fine particulate matter (PM2.5) on cardiac electrophy-
siology, blood coagulation, and systemic inflammation.
Recruitment methods for the APACR study have been
published elsewhere [28,29]. All study participants were
recruited from communities in central Pennsylvania, pri-
marily from the Harrisburg metropolitan area. The
inclusion criteria for the study included nonsmoking
adults, ≥ 45 years old, who had not been diagnosed with
severe cardiac problems (defined as diagnosed valvular
heart disease, congenital heart disease, acute myocardial
infarction or stroke within 6 months, or congestive
heart failure). Approximately 75% of the individuals who
were contacted and who met our inclusion criteria were
enrolled in the APACR study. Our targeted sample size
was 100 individuals, and we enrolled and examined 102
individuals in the APACR study.
Study participants were examined in the General Clin-
ical Research Center (GCRC) during the morning hours
of Day 1, between 8:00 AM and 10:00 AM. After admin-
istering the informed consent, the participants com-
pleted a health history questionnaire. A trained research
nurse measured seated blood pressure three times,
height, weight, and drew 50 ml of blood for blood bio-
marker assays according to the blood sample prepara-
tion protocols. A trained investigator connected the
PM2.5 and Holter electrocardiography (ECG) recorders.
Participants were given an hourly activity log to record
special events that occurred during 24 hours, including
outdoor activities, exposure to traffic on the street, tra-
vel in an automobile, and any physical activities. Before
participants were released, they received detailed
instructions on how to operate both monitors. The
entire session lasted approximately 1 hour. The next
morning (Day 2), the participants came back to the
GCRC to disconnect the PM2.5 and Holter monitors,
return the completed activity log, have another 50 ml of
blood drawn, and provide a urine sample. Then, an
exercise echocardiography was performed on each parti-
cipant according to a standardized protocol (Bruce pro-
tocol) to measure the participant’s ventricular function
and structure. The entire Day 2 session lasted approxi-
mately 1 hour and 45 minutes. The study protocol was
approved by the Penn State University College of Medi-
cine Institutional Review Board (IRB). All participants
gave written informed consent prior to their participa-
tion in the study. Each participant was reimbursed with
$50.00, a breakfast certificate in the hospital cafeteria,
and the mileage of the transportation required for parti-
cipating in the study.
Assessment of insulin resistance: insulin, glucose,
and HOMA-IR
During the Day 1 visit, after an overnight fast, blood was
drawn from each participant. Fasting glucose and insulin
were measured by the Penn State College of Medicine
GCRC central laboratory. HOMA-IR was calculated as
[fasting insulin (μU/mL) Ø fasting glucose (mmol/L)/
22.5], with higher HOMA-IR values indicative of more
IR [5].
Continuous Holter ECG recording
Continuous ambulatory ECG
A high-fidelity (sampling frequency 1,000 Hz) 12-lead
HScribe Holter System (Mortara Instrument, Inc.,
Milwaukee, WI) was used to collect the 24-hour Holter
beat-to-beat ECG data. The high-fidelity ECG signifi-
cantly increases the resolution and enhances the accu-
racy of various wave form measurements. All Holter
recordings started between 9:00 AM and 10:00 AM. The
Holter ECG data were scanned to a designated compu-
ter for offline processing by an experienced investigator
using specialized SuperECG software (Mortara Instru-
ment, Inc.). The standardized operation procedures
(SOPs) for the APACR study developed by the study
investigators were followed rigorously in the data collec-
tion, offline processes, HRV analysis and interpretation
processes. Briefly, the Holter ECG Data Collection and
Analysis Procedures were followed to prepare, hook up,
calibrate, and start the Holter digital recorder. After
24 hours of recording, a trained investigator followed
the SOP to retrieve and archive the beat-to-beat ECG
data for offline processing. The main objective of the
offline processing was to verify the Holter-identified
ECG waves and to identify and label additional
Rodríguez-Colón et al. Cardiovascular Diabetology 2010, 9:85
http://www.cardiab.com/content/9/1/85
Page 2 of 10electronic artifacts and arrhythmic beats in the ECG
recording. Finally, a single research investigator per-
formed beat-to-beat HRV analysis using the normal
beat-to-beat RR interval data.
Cardiac autonomic modulation (CAM) measures
The entire 24-hour normal beat-to-beat RR interval data
were divided into 30-minute segments of RR data. Thus,
each individual provided 48 segments of 30-minute RR
data. The RR data for HRV analysis were processed
according to current recommendations [9]. Within each
segment, any RR interval <400 ms, >2000 ms, or where
the ratio from two adjacent RR intervals was <0.80 or
>1.20 were excluded from the HRV analysis. The time-
and frequency-domain HRV analysis were performed on
the remaining normal RR interval data if the total length
of such normal RR intervals was greater than 20 min-
utes (67% of original data), using the HRV Analysis Soft-
ware v1.1 [30]. When performing frequency-domain
HRV analysis, we used Fast Fourier Transformation
(FFT). Briefly, the adjacent RR interval data were inter-
polated using a piecewise cubic spline approach, with a
2 Hz sampling rate. The FFT was performed on the
equidistantly interpolated RR time series. We used a
second order polynomial model to remove the slow
non-stationary trends of the HRV signal. The following
HRV indices were calculated as measures of CAM: stan-
dard deviation of all RR intervals (SDNN, ms), square
root of the mean of the sum of the squares of differ-
ences between adjacent RR intervals (RMSSD, ms),
power in the high frequency range (0.15-0.40 Hz, HF),
power in the low frequency range (0.04-0.15 Hz, LF),
the ratio of LF to HF (LF/HF), and in the very low fre-
quency power (0.00-0.04 Hz, VLF). Following current
recommendations [9], we performed logarithmic trans-
formations on HF and LF prior to statistical analysis.
Covariables
A standardized questionnaire administered on Day 1 to
the participants was used to collect the following indivi-
dual-level information: (1) demographic variables,
including age, race, sex, and highest education level; (2)
medication uses, including anti-hypertensive medication
and glucose lowering medications; and (3) physician
diagnosed chronic disease history, including coronary
heart disease (e.g., revascularization procedures and
myocardial infarction), hypertension, and diabetes. Body
weight and standing height were obtained in the morn-
ing of Day 1 and were used to calculate body mass
index (BMI) as weight (kg)/height (m
2). Seated blood
pressure was obtained three times after 5 minutes of
resting. The averages of the second and third measures
of seated systolic and diastolic blood pressures were
used to represent a participant’s blood pressure levels.
Hypertension was defined as systolic blood pressure
≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or
physician diagnosed hypertension and currently using
anti-hypertensive medication. History of CVD was
defined as having a physician diagnosed history of myo-
cardial infarction or coronary arterial revascularization
procedures. Type 2 diabetes was defined as fasting
glucose > 126 mg/dL, physician diagnosed type 2 diabetes,
or currently using glucose lowering medication.
Statistical analysis
From the 102 individuals, we excluded 8 participants with
type 2 diabetes. As a result, this report used the data from
the remaining 94 individuals. Each individual contributed
up to 48 segments of 30-minute RR interval data. After
excluding segments where the total length of RR interval
data was less than 20 minutes, we analyzed 4404 segments
of 30-minute HRV data from 94 individuals.
A two-stage analysis was performed to assess the rela-
tionship between IR measures and the circadian pattern
of HRV. At the first stage, for each individual we fit the
HRV data based on all available 30-minute segments to
ac o s i n ep e r i o d i cr e g r e s s i o nm o d e l[ 3 1 ]u s i n gn o n l i n e a r
least squares: HRVi(t) = Mi +A i￿cos [2π ￿(t-θi)/T] + εi,
i = 1, ..., 94, in which Mi is the daily average of HRV of
the i
th subject, Ai is the amplitude of HRV of the i
th
s u b j e c ta r o u n dM i, t is the time-specific segment order
number, T is the total number of 30-minute segments
in 24 hours, θi is the acrophase (the lag from the refer-
ence time point (9:00 AM) to the time of the zenith of
the cosine curve fit to the data of the i
th subject), and εi
is the error term of the i
th subject. One unit of t corre-
sponds to 30 minutes, with 1 indicating 9:00 AM to
9:30 AM, 2 indicating 9:30 AM to 10:00 AM, etc. Thus,
from the above described cosine model, we obtained the
estimated individual-level cosine periodic regression
parameters, namely the M, Â, and θ to quantify the per-
iodicity of the HRV variables. At the second stage, we
used random-effects meta-analyses to obtain overall esti-
mates of M, Â and θ, and their 95% confident intervals
(CIs) to assess the associations between IR and the three
components of the circadian pattern of HRV [32].
Because HOMA-IR and fasting insulin were not nor-
mally distributed, we used a logarithmic transformation
for these two IR variables before performing the analy-
sis. To visualize the impact of elevated IR on the three
circadian parameters, we plotted the population level
circadian pattern of HF, and superimposed the circadian
pattern predicted HF from one standard deviation
increase in HOMA-IR. To confirm the associations
between the IR and the means from the random-effects
meta-analysis models, we also applied linear mixed-
effects models, specifying a first-order autoregressive
covariance structure, to assess the associations between
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lyzing the daytime (9 AM to 9 PM) and nighttime
(9 PM to 9 AM next day) data separately. This model
will also enable us to examine whether IR affect daytime
and nighttime autonomic modulation differently. In this
approach we ignored the assumption of the specific
cosine form for the data and treated the HRV variables
from each 30-minute segment as repeated measures. All
analyses were performed using SAS version 9.1 software
(SAS Institute Inc., Cary, NC, USA).
Results
Study population characteristics
The main characteristics of the study population are
shown in Table 1. From the first 102 APACR study
enrollees, we excluded 8 individuals who had a history
of type 2 diabetes. The sample size for this analysis was
94 individuals. The mean (SD) age of the entire study
population was 56.5 (7.8) years old, with 37% male and
77% white. The prevalence of CVD was 7.4%. In addi-
tion, the mean (SD) for BMI (kg/m
2), insulin (μU/mL),
glucose (mg/dL), and HOMA-IR of the entire cohort
were 27.1 (4.9), 6.6 (6.7), 84.4 (11.3), and 1.45 (1.73)
respectively. The means (SD) for the HRV indices: log
HF, log LF, LF/HF ratio, log VLF, SDNN, RMSSD, and
HR were 4.4 (0.9), 5.4 (0.8), 3.8 (2.2), 6.9 (0.6), 61.8
(18.4), 29.6 (14.8), and 76.5 (9.7), respectively.
Circadian pattern of HRV variables
The estimated means of the three cosine periodic
regression parameters and their 95% CIs for each of the
HRV indices are presented in Table 2. The acrophases
of log HF and RMSSD (both are reflective of the vagal
modulation) were very similar, 4:00 AM and 4:15 AM,
respectively. The acrophases of log LF and SDNN (both
are reflective of sympathetic and vagal modulation) were
also very similar - the point estimates are around
6:00 AM ± 45 minutes. The acrophase of log VLF was
8:00 AM, LF/HF ratio was 6:00 PM, and that of heart
rate was 2:00 PM. The tests of zero amplitude were
highly significant (P value < 0.0001) for every HRV vari-
able, suggesting a significant circadian variation.
Insulin resistance and HRV circadian pattern
The associations between the IR measurements and
cosine parameters of the circadian pattern (M, Â, and
θ) estimated from the entires a m p l eu s i n gr a n d o m -
effects meta-analysis models are presented in Table 3.
Two different random-effects meta-analysis regression
models were reported: Model 1, unadjusted; Model 2,
adjusted for age sex, race, hypertension, and history of
CVD. In general, higher levels of IR, especially IR mea-
sured by HOMA-IR, was significantly associated with
Table 1 The study population demographic
characteristics and summaries of HRV indices
Demographics All subjects (n = 94)
Age (years) 56.5 (7.8)
Gender (% male) 37.2
Race (% white) 76.6
BMI (kg/m
2) 27.1 (4.9)
College or higher (%) 78.2
Cardiovascular disease (%) 7.4
Hypertension (%) 33.0
Systolic BP (mmHg) 122.0 (15.4)
Diastolic BP (mmHg) 75.0 (9.3)
Insulin (μU/mL) 6.6 (6.7)
Log insulin (μU/mL) 1.5 (0.8)
Glucose (mg/dL) 84.4 (11.3)
HOMA-IR 1.45 (1.73)
Log HOMA-IR -0.030 (0.86)
HRV indices*:
Log of HF (ms
2) 4.4 (0.9)
Log of LF (ms
2) 5.4 (0.8)
LF/HF ratio 3.8 (2.2)
Log of VLF (ms
2) 6.9 (0.6)
SDNN (ms) 61.8 (18.4)
RMSSD (ms) 29.6 (14.8)
Heart rate (BPM) 76.5 (9.7)
Abbreviations: BMI, body mass index; BP, blood pressure; BPM, beats per
minute; HF, high frequency power; HOMA-IR, homeostasis model assessment
of insulin resistance; HRV, heart rate variability; LF, low frequency power; Log,
logarithm; RMSSD, square root of the mean of the sum of the squares of
differences between adjacent RR intervals; SDNN, standard deviation of all RR
intervals; VLF, very low frequency power.
Data are expressed as mean (SD) or percentage.
*: Overall average of the intra-subject means.
Table 2 Estimated means of the three cosine periodic
regression parameters and their 95% CIs for each HRV
index
Cosine periodic parameter
HRV index Mean
(95% CI)
Amplitude
(95% CI)
Acrophase
(95% CI)
†
Log HF (ms
2) 4.36 (4.17-4.54) 0.60 (0.53-0.67)* 4:00(3:00-5:00) AM
Log LF (ms
2) 5.36 (5.21-5.52) 0.44 (0.39-0.49)* 5:30(4:30-6:45) AM
LF/HF ratio 3.74 (3.33-4.15) 1.16 (0.98-1.34)* 6:00(4:30-7:15) PM
Log VLF (ms
2) 6.95 (6.83-7.07) 0.39 (0.35-0.44)* 8:00(7:00-9:00) AM
SDNN (ms) 60.8 (57.2-64.4) 10.5 (9.3-11.7)* 6:45(5:45-7:30) AM
RMSSD (ms) 28.4 (25.7-31.0) 7.24 (6.10-8.37)* 4:15(3:15-5:15) AM
Heart rate
(BPM)
76.6 (74.6-78.6) 10.8 (9.8-11.7)* 2:00(1:45-2:30) PM
Abbreviations: BPM, beats per minute; CIs, confidence intervals; HF, high
frequency power; HRV, heart rate variability; LF, low frequency power; Log,
logarithm; RMSSD, square root of the mean of the sum of the squares of
differences between adjacent RR intervals; SDNN, standard deviation of all RR
intervals; VLF, very low frequency power.
*: P value < 0.0001 for zero amplitude test of the HRV indices.
†: Calculated as the unit to peak ± 2 standard errors, and translated into clock
time.
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unadjusted and multivariable adjusted models, except
that LF/HF ratio was not significantly associated with
any measure of IR. In this healthy non-diabetes sample,
IR was not significantly associated with the Â or θ of
any HRV indices. Log VLF was also included in Table 3
as a HRV variable that may be reflective of nocturnal
sympathetic hyperactivity. The association between IR
measures and VLF is very similar to that of HF and
LF - elevated insulin resistance is only associated with
lower mean levels of VLF, but not with the amplitude
or the acrophase.
The circadian variation of Log HF calculated from the
entire population is graphically presented in Figure 1. The
predicted circadian pattern of Log HF due to a one SD
increase in HOMA-IR is superimposed in Figure 1 to gra-
phically illustrate the impact of elevated IR on the circa-
dian pattern of log HF. It clearly show, similar to the
numeric numbers in Table 3, that one SD increase in IR is
associated with lower overall mean [b (M)] of Log HF, but
not with the other two circadian parameters (Â and θ).
We also performed additional analyses examining the
associations between HOMA-IR and HRV cosine para-
meters of circadian pattern in 8 individuals with physi-
cian-diagnosed type 2 diabetes. These analyses were
preformed in an unadjusted model because small sam-
ple size. The results are presented in Table 4. Com-
pared to that regression coefficients in Table 3 Model 1,
the magnitude of effect due to higher Log HOMA-IR
on the mean (M), amplitude (Â), and acrophase time
(θ), are much larger among persons with type 2 dia-
betes, a group that clinically have more severe form of
insulin resistance. Because of the small sample size,
most of the statistical tests of the regression coefficients
in Table 4 did not reach traditional significant level
(P value < 0.05).
I g n o r i n gt h es p e c i f i cc o s i n ef o r mf o rt h ed a t aa n d
treating HRV variables from each 30-minute segment
as repeated measures, the regression coefficients, SE,
and P value relating HOMA-IR and HRV indices
according to daytime (9 AM to 9 PM) and nighttime
(9 PM to 9 AM next day) are presented in Table 5.
Table 3 The association between cosine parameters of circadian pattern with insulin resistance measures based on
random-effects meta-analysis
HRV index
Log HF (ms
2) Log LF (ms
2) LF/HF ratio Log VLF(ms
2) SDNN (ms) RMSSD (ms) Heart Rate (bpm)
Beta SE Beta SE Beta SE Beta SE Beta SE Beta SE Beta SE
Log HOMA-IR M1 M -0.25 0.09** -0.24 0.08** 0.11 0.21 -0.19 0.06** -4.89 1.76** -3.35 1.31** 2.14 0.99*
Â 0.04 0.03 -0.01 0.03 0.15 0.09 0.01 0.02 -0.19 0.61 -0.34 0.59 -0.28 0.48
θ 0.11 0.91 1.33 1.12 -1.56 1.35 0.22 0.91 -0.60 0.91 -1.24 1.00 0.47 0.33
M2 M -0.28 0.10** -0.28 0.08** 0.08 0.22 -0.23 0.07** -5.90 1.90** -3.50 1.45* 2.57 1.11*
Â 0.01 0.04 -0.01 0.03 0.08 0.10 0.03 0.03 -0.002 0.67 -0.61 0.67 -0.16 0.54
θ 0.22 1.04 1.04 1.26 -0.07 1.42 -0.02 1.01 -0.22 1.02 -1.14 1.12 0.26 0.37
Log insulin M1 M -0.23 0.09* -0.23 0.08** 0.05 0.21 -0.18 0.06** -4.41 1.75** -3.03 1.30* 1.94 1.00
Â 0.04 0.03 -0.02 0.03 0.14 0.09 0.01 0.02 -0.21 0.60 -0.18 0.58 -0.09 0.48
θ -0.40 0.94 0.91 1.14 -1.84 1.33 0.13 0.92 -0.87 0.92 -1.84 1.01 0.46 0.33
M2 M -0.25 0.10** -0.26 0.08** 0.04 0.21 -0.20 0.06** -5.21 1.89** -3.15 1.44* 2.18 1.12*
Â 0.02 0.04 -0.01 0.03 0.08 0.09 0.02 0.02 0.04 0.66 -0.35 0.65 0.07 0.54
θ -0.41 1.07 0.47 1.27 -0.44 1.39 -0.26 1.02 -0.70 1.03 -1.82 1.13 0.24 0.36
Glucose M1 M -0.20 0.09* -0.17 0.08* 0.21 0.21 -0.16 0.06** -4.05 1.79* -2.31 1.34 1.04 1.01
Â -0.01 0.03 0.02 0.03 0.10 0.09 0.03 0.02 0.42 0.61 -0.81 0.59 -0.83 0.47
θ 1.36 0.90 1.43 1.12 0.92 1.35 -0.21 0.91 0.07 0.92 1.42 1.02 0.08 0.34
M2 M -0.16 0.10 -0.18 0.08* 0.08 0.22 -0.18 0.07** -4.41 1.93* -1.84 1.48 1.79 1.12
Â -0.04 0.04 0.01 0.03 0.05 0.10 0.05 0.02 0.32 0.67 -1.25 0.66 -0.88 0.53
θ 1.85 1.02 1.82 1.24 1.91 1.39 0.32 0.98 1.19 0.10 1.87 1.13 -0.05 0.37
Abbreviations: Â, amplitude; BPM, beats per minute; HF, high frequency power; HOMA-IR, homeostasis model assessment of insulin resistance; HRV, heart rate
variability; LF, low frequency power; Log, logarithm; M, mean; RMSSD, square root of the mean of the sum of the squares of differences between adjacent RR
intervals; SDNN, standard deviation of all RR intervals; VLF, very low frequency power; θ, acrophrase time.
Models: M1, unadjusted; M2, adjusted for age, sex, race, hypertension, and cardiovascular diseases.
Beta = one SD increase of insulin resistance measurements. *, and **, P < 0.05, and P < 0.01, respectively.
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associated with lower HRV indices, and the patterns of
association are similar daytime and night time.
Discussion
The estimated means and their 95% CIs of the three
cosine periodic regression parameters presented in
Table 2 clearly show a distinctive 24-hour based circa-
dian rhythm of HRV indices. For instance, using Log
HF as an example, a recognized HRV marker of
parasympathetic modulation, had an overall mean of
4.36 ms
2 and reached the acrophase (highest amplitude
of Â = 0.60 ms
2) around 4:00 AM. Furthermore, the
t e s t so fz e r oa m p l i t u d ew e r eh i g h l ys i g n i f i c a n t( P value
< 0.0001) for every HRV variable, suggesting a signifi-
cant circadian variation. The mean (M), amplitude (Â),
and acrophase time (θ) together define the circadian
pattern of HRV, which is reflective of the balance of
two opposing autonomic modulation branches, namely
parasympathetic and sympathetic modulations.
        Population mean of log HOMA-IR = -0.0296 
        ȕ0 ȕÂ)= 0.602; ȕș 
- - - One SD increase of log HOMA-IR = 0.828
       ȕ0 ȕÂ) = 0.617; ȕș= 38.9
Figure 1 Multivariable adjusted (Model 2) cosine periodic model estimates for log HF over the clock time at the population mean and
one SD above the mean in log HOMA-IR. Abbreviations: Â, amplitude; HF, high frequency power; HOMA-IR, homeostasis model assessment of
insulin resistance; log, logarithm; M, mean; SD, standard deviation; θ, acrophrase time.
Table 4 The association between cosine parameters of circadian pattern with Log HOMA-IR based on random-effects
meta-analysis of 8 physician diagnosed type 2 diabetes individuals
HRV index
Log of HF (ms
2) Log of HF (ms
2) SDNN (ms) RMSSD (ms) LF/HF Ratio Heart Rate (BPM)
Beta SE Beta SE Beta SE Beta SE Beta SE Beta SE
Log HOMA-IR M1 M -0.57 0.29 -0.48 0.28 -6.14 8.12 -3.20 4.56 0.28 0.27 0.30 3.39
Â -0.03 0.15 -0.003 0.12 -0.35 2.39 -2.30 1.24 0.04 0.17 -2.19 1.21
θ 7.56 3.64 4.36 4.15 6.99 3.32 9.04 3.49* 2.51 4.28 0.97 1.63
Abbreviations: Â, amplitude; BPM, beats per minute; HF, high frequency power; HOMA-IR, homeostasis model assessment of insulin resistance; HRV, heart rate
variability; LF, low frequency power; Log, logarithm; M, mean; RMSSD, square root of the mean of the sum of the squares of differences between adjacent RR
intervals; SDNN, standard deviation of all RR intervals; VLF, very low frequency power; θ, acrophrase time.
M1: unadjusted model; Beta: one SD increase of Log HOMA-IR.
*=P < 0.05
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Page 6 of 10Past epidemiological studies performed in different
populations investigating the relationship between IR
and the overall mean levels of HRV indices have shown
that elevated IR has a significant adverse effect on the
overall mean levels of CAM [17,33]. Pikkujämsä et al.
demonstrated that subjects with IR syndrome have
reduced HRV indices [17]. In addition, Perciaccante et
al. confirmed that impaired autonomic activity was pre-
sent in IR patients [33]. On the other hand, other stu-
dies have shown that individuals without type 2 diabetes
or offspring of type 2 diabetic persons, even when their
glucose was in the normal range, had lower HRV indices
[14,16,34]. Stein et al. found that in non-diabetic indivi-
duals with normal fasting glucose levels, higher glucose
levels [14] and higher HOMA-IR [16] were associated
with faster heart rate and lower HRV. In addition,
Fiorentini et al. showed that higher HOMA-IR was asso-
ciated with autonomic impairment among the offspring
of individuals with type 2 diabetes, even when they had
no history of type 2 diabetes, normal glucose tolerance
test, and no history of hypertension [34]. Similar to
these previous findings, in this community-dwelling
sample of healthy non-smokers without type 2 diabetes,
we found that a higher level of IR is significantly asso-
ciated with lower mean levels of HRV. The pattern of
these associations remained significant after adjustment
f o ra g e ,s e x ,r a c e ,h y p e r t e n s i o n ,a n dh i s t o r yo fC V D .
This conclusion is also supported in the analysis treating
HRV variables from each 30-minute segment as
repeated measures, and stratified according to daytime
(9 AM to 9 PM) and nighttime (9 PM to 9 AM next
day). Moreover, the daytime and night time stratified
model suggest a similar daytime and nighttime associa-
tion between IR and CAM.
To our knowledge, none of the previously published
studies investigated the effects of IR on the other two
parameters of HRV circadian pattern, the amplitude and
the acrophase. In this study, we used a two-stage analy-
tic approach to first obtain individual-level cosine func-
tion parameters (M, Â, and θ) from 24 hours of HRV
data, and then used a random-effects meta-analysis
regression model to investigate the impact of IR on each
of the circadian cosine parameters. This approach allows
us to estimate the impact of IR, not only on overall
mean levels of HRV variables as in previously published
studies, but it also enabled us to examine the impact of
IR on the amplitude and acrophase time of HRV. In our
data obtained from obviously healthy non-diabetics and
non-smokers, IR was not associated with impaired circa-
dian variation of HRV as suggested by lack of associa-
tion between amplitude and acrophase time of HRV
index and IR.
In humans, circadian rhythms in blood pressure
[35,36], and in heart rate have been intensively studied,
mainly due to the increased cardiovascular death
reported during the morning hours [37,38]. There are a
large number of different biological circadian rhythms,
including numerous aspects of cardiovascular functions
[39]. These are generated by an endogenous oscillator,
composed of a central clock which resides in the
hypothalamic suprachiasmic nucleus (SCN), and periph-
eral clock in peripheral tissues [40]. These two have an
important role in the timing and organization/coordina-
tion of sleep with other physiological rhythms, such as
the balance of autonomic modulation [41]. The central
clock is composed of self-sustaining single cell circadian
oscillators which produce circadian signals [40,42].
These oscillators are not precisely 24 hours, so they
Table 5 The regression coefficients (b) estimates and standard error (SE) of Log-HOMA-IR on HRV indices using
24-hour data, daytime (9 AM to 9 PM) and nighttime (9 PM to 9 AM next day) data separately from linear mixed-
effects models analysis
HRV index
Log of HF (ms
2) Log of LF (ms
2) SDNN (ms) RMSSD (ms) LF/HF Ratio Heart Rate (bpm)
Beta SE Beta SE Beta SE Beta SE Beta SE Beta SE
Log HOMA-IR M 1 24-h -0.23 0.028** -0.24 0.021** -3.58 0.31** -1.93 0.34** 0.086 0.062 2.85 0.41**
day -0.26 0.034** -0.22 0.027** -3.44 0.38** -1.86 0.35** 0.35 0.083** 2.80 0.60**
night -0.19 0.043** -0.26 0.030** -3.73 0.49** -1.87 0.58** -0.18 0.092* 2.88 0.52**
M 2 24-h -0.32 0.028** -0.29 0.021** -4.85 0.33** -2.64 0.37** 0.27 0.066** 3.34 0.46**
day -0.33 0.035** -0.28 0.029** -4.31 0.39** -2.32 0.37** 0.52 0.086** 3.21 0.68*
night -0.30 0.040** -0.31 0.032** -5.40 0.52** -2.78 0.62** 0.011 0.10 3.36 0.58**
Abbreviations: BPM, beats per minute; HF, high frequency power; HOMA-IR, homeostasis model assessment of insulin resistance; HRV, heart rate variability; LF,
low frequency power; Log, logarithm; M, mean; RMSSD, square root of the mean of the sum of the squares of differences between adjacent RR intervals; SDNN,
standard deviation of all RR intervals.
Models: M1, unadjusted; M2, adjusted for age, sex, race, hypertension, and cardiovascular diseases.
Beta = one SD increase of Log HOMA-IR.
*, and **, P < 0.05, and P < 0.001, respectively.
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Page 7 of 10adjust to the external light/dark signal from the retino-
hypothalamic tract [40,42]. These signals give informa-
tion about the 24-hour day pattern, the relative
proportion of light/dark, and the amplitude of light
intensity that tracks the seasons [43]. Most of the
peripheral tissue cells have similar oscillations like the
SCN [44].
Various animal studies have examined the impact of
disruption clock genes [45-48]. Turek et al. showed that
homozygous Clock mutant mice had a loss of sense
mutation, lost circadian rhythmicity, became obese, and
developed hyperglycemia among other health problems
[32]. Rudic et al. showed that mutations in Bmal and
Clock modified circadian variation in glucose and trigly-
cerides and influenced the development of IR [46].
Marcheva et al. found that phase of oscillation of islet
genes involved in growth, glucose metabolism and insu-
lin signaling is delayed in circadian mutant mice, and
both Clock and Bmal1 mutants show reduce insulin
secretion, and impaired glucose tolerance [47].
Researchers have been concerned over the disruption
of these circadian rhythms in the human clock, which
regulate the metabolism in time with day length [49,50].
For example, glucose and insulin have been shown to
exhibit diurnal variation in humans [50]. The normal
physiological variation of these variables between day and
night could be lost (with an increase over the 24 hours)
contributing to the development of CVD [50] or IR.
Earlier studies have investigated the circadian rhythm
of HRV in humans [15,51,52]. Huikuri et al. observed
that the circadian rhythm of HRV (measured from a
24-hour ECG) in healthy subjects had a maximum
occurring early in the morning before waking up,
reflecting higher parasympathetic tone, but decreased
abruptly during the hours after waking [51]. Malpa et al.
found that HRV variation over 24 hours in alcoholics
and persons with diabetes was significantly reduced
compared to normal controls [25]. Huikuri et al.
demonstrated that there was a circadian pattern of HRV
in both survivors of cardiac arrest and controls, with
acrophase occurring in the morning hours before arou-
sal, followed by a decrease in HRV after arousal; how-
ever there was low vagal modulation in survivors of
cardiac arrest in the morning [52].
To our knowledge, the effects of IR on the circadian
rhythm (amplitude and acrophase time) of HRV have
not been reported in the literature. The aim of this
study was to investigate the association between IR and
the circadian pattern of CAM assessed by three circa-
dian cosine parameters of HRV. In our data, higher
levels of IR, as assessed by HOMA-IR, fasting insulin, or
fasting glucose, were significantly associated with lower
mean levels of HRV. However, IR in this obviously
healthy non-diabetic and nonsmoking population sample
was not associated with impaired circadian variation of
HRV indices, i.e., lower amplitude and acrophase time
of any HRV index. This lack of significant effects on the
circadian pattern of HRV variation, indicates that the
burden of IR in our healthy study population is not
large enough to exert its effects yet. We speculate that
with prolonged burden of elevated subclinical IR, possi-
bly long before full manifestation of clinical diabetes, all
three circadian parameters of CAM may be adversely
affected. This is supported by the analysis of the associa-
tions between Log HOMA-IR and HRV cosine para-
meters of circadian pattern in 8 individuals with
physician-diagnosed type 2 diabetes (Table 4). Specifi-
cally, the adverse effects of increased IR on all three
HRV circadian parameters, namely the mean (M),
amplitude (Â), and acrophase time (θ), are much larger
among persons with type 2 diabetes, a group that clini-
cally have more severe form of IR.
Future longitudinal studies are needed to investigate
this hypothesis. From a practical stand point, the results
of lack of effects on the circadian pattern of HRV also
suggest that early interventions to enhance insulin sensi-
tivity, such as physical activity, may be helpful to pre-
serve the circadian pattern of CAM.
A few limitations of this study should be recognized.
First, our cross-sectional data limited our ability to
establish a temporal relationship. Thus, our results sup-
port the need for a longitudinal study to investigate the
complex relationships between IR and CAM assessed by
circadian variation of HRV indices. Second, we only col-
lected data from nonsmokers who did not have physi-
cian diagnosed heart disease in the 6 months prior to
participating in our study. Therefore, our findings can-
not be generalized to smokers or individuals with recent
acute cardiac events. However, there are several
strengths worth mentioning. First, the characteristics of
this population were very similar to those in the general
population. We analyzed several variables that are char-
acteristics of IR, including insulin, glucose, and HOMA-
IR. These variables, especially HOMA-IR, are considered
reliable quantitative measures of IR before clinical dia-
betes [4,5]. Second, distinct from previous publications,
which primarily analyzed short time HRV variables,
[17,53] we utilized cosine periodic functions to fit indivi-
dual-level models to the 24 hours of HRV data to esti-
mate the individual-level mean, as well as amplitude and
crescent time, of each HRV variable. This enabled us to
examine not only the impact of various independent
variables, such as HOMA-IR, on the mean levels of
HRV variables, but also allowed us to examine the
impact of such variables on the other circadian cosine
parameters of the HRV indices.
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In this cross-sectional study of community dwelling
non-smokers, after excluding the few individuals with a
history of diabetes, subclinical IR only exhibited signifi-
cant adverse effects on the mean levels of HRV. The
subclinical IR in this sample did not show an adverse
impact on the amplitude and the acrophase time of the
circadian cosine parameters. It might be anticipated that
with fully manifested diabetes, the consequence of pro-
longed IR, the entire circadian variation of CAM will be
adversely affected. From a practical stand point, these
data suggest the potential for early intervention to
improve insulin sensitivity and to preserve the circadian
pattern of CAM, which is protective from cardiovascular
adverse events.
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